WITOWSKI, Phd, Christopher G.,SALM, Phd, Jacqueline L.
申请号：
AU2019206649
公开号：
AU2019206649A1
申请日:
2019.01.11
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Preparation, of cannabinoid formulations containing: Δ9-tetrahydrocannabinol (Δ9- THC), Δ8-tetrahydrocannabinol (Δ8-THC), A9-tetrahydrocannabinolic acid (THCa), cannabidiol (CBD), cannabidiolic acid (CBDa), cannabigerol (CBG), cannabichromene (CBC) and cannabinol (CBN), either alone or in combinations henceforth known as cannabis, have been created using an emulsification process to encapsulate cannabinoids. The aqueous-based method involves micellular encapsulation of cannabinoids, a method that has been used to increase the bioavailability of poorly permeable, lipophilic drugs. The present invention demonstrates the viability of transdermal delivery with gels and patches for consistent and sustained cannabinoid dosing.
